homeeconomy NewsNitin Sandesara of Sterling Biotech: The pharma tycoon behind Rs 5,000 crore loan fraud case

Nitin Sandesara of Sterling Biotech: The pharma tycoon behind Rs 5,000 crore loan fraud case

His company allegedly took loans of more than Rs 5,000 crore from a consortium led by Andhra Bank, which it failed to pay, after which the loans were classified as non-performing assets.

Profile image

By Shubham Singh  Sept 25, 2018 8:32:00 AM IST (Updated)

Listen to the Article(6 Minutes)
Nitin Sandesara of Sterling Biotech: The pharma tycoon behind Rs 5,000 crore loan fraud case
Nitin Sandesara, the absconding director of Gujarat-based Sterling Biotech, is accused of perpetrating a Rs 5,000-crore fraud and is likely to have fled to Nigeria after being arrested in Dubai, according to media reports. He was wanted by the CBI and the ED in the scam.

Share Market Live

View All

His family includes brother Chetan Sandesara and sister-in-law Diptiben Sandesara who are likely to have been hiding in Nigeria.
Nitin Sandesara is a chartered accountant entrepreneur and the head of Sandesara Group and has played a major role by diversifying the Sandesara group of companies in several businesses such as tea, Gelatin and engineering.
He serves as the chairman and director at Sterling Exploration and Energy Production Company Limited.
As per the website, “The Sandesara group is a diversified group with varied interests in high growth industries. We have an estimated group valuation of $6.9 billion and have over 25 years of industrial experience. We have business interests in Pharmaceuticals, Healthcare, Oil & Gas, Engineering, Infrastructure, Onshore rigs, Seismic studies and Oil trading."
The company has allegedly taken loans of over Rs 5,000 crore from a consortium led by Andhra Bank. The consortium has accused Sterling of not paying back the loans after which they have been classified as non-performing assets.

Most Read

Share Market Live

View All
Top GainersTop Losers
CurrencyCommodities
CurrencyPriceChange%Change